The electrophysiologic properties of diphenylhydantoin (DPH) (5-10 mg/kg) intravenously was studied in 14 subjects using His bundle recordings and correlated with blood levels. Conduction through the A-V conducting system (AVCS) was studied at various paced atrial rates and refractory periods determined using programmed atrial premature depolarization within 10 min of drug administration. In 11 of 14 subjects the sinus cycle length was shortened by an average of 110 msec, lengthened in three (average 116 msec). Conduction through the A-V node (AVN) was shortened in seven subjects (average 10 msec), lengthened in one (5 msec), and unchanged in the remaining six. Conductinged by 5 msec). Prior to DPH, the longest mained constant in all but two subjects (proloengthened in four, and was unchanged in the rerefractory period of the AVCS was in the AVN in nine subjects, the atrium in four and the HPS in one. After DPH, the following effects were noted: (1) the effective refractory period (ERP) of the atria shortened in four subjects, lengthened in four, and was unchanged in the remaining six; (2) the ERP of the AVN shortened in 6/9 subjects, lengthened in 3/9; (3) functional refractory period of AVN shortened in si, prolonged in three subjects, and remained unchanged in five subjects; (4) the relative refractory period (RRP) of the HPS shortened in 7/7 subjects; (5) ERP of HPS in 1/1 subject shortened. Thus, DPH showed varied effects on A-V nodal conduction, inconsistent effect in the atrium, and consistent shortening of the refractorv period of the HPS. The data suggest DPH differs from other antiarrhythmic drugs such as quinidine and procaine amide. Received January 2, 1973; revision accepted for publication March 6, 1973. nously administered DPH has on refractoriness of the atrium, A-V node, and His-Purkinje system at paced cycle lengths. Measurements were also made of A-V nodal and His-Purkinje conduction time over a range of paced atrial rates. Correlation of the electrophysiologic effects with plasma levels were made.
DIPHENYLHYDANTOIN (DPH) has been
used to treat a variety of cardiac arrhythmias occurring under different clinical situations.' 12 The results of a number of studies using isolated atrial muscle and Purkinje fiber preparations indicate that the electrophysiologic properties of DPH differ from those of other drugs such as procaine amide and quinidine. [13] [14] [15] [16] 18 Some reports indicate that DPH enhances A-V nodal conduction time in the intact animal and human hearts"' 12. 17 while others noted a depression of A-V nodal conduction. 9 [20] [21] [22] The present study, involving 14 human subjects, was undertaken to determine what effects intrave- nously administered DPH has on refractoriness of the atrium, A-V node, and His-Purkinje system at paced cycle lengths. Measurements were also made of A-V nodal and His-Purkinje conduction time over a range of paced atrial rates. Correlation of the electrophysiologic effects with plasma levels were made.
Materials and Methods
Fourteen subjects underwent right heart catheterizations in the postabsorptive, nonsedated state. A signed consent was obtained for each patient. The presence or absence of heart disease was determined by clinical history, physical examination, chest X-ray, ECG, and cardiac catheterization when indicated. The essential clinical data are presented in table 1. Under local anesthesia, a quadripolar electrode catheter was introduced percutaneously into the right antecubital vein and fluoroscopically positioned against the lateral wall of the high right atrium near its junction with the superior vena cava. The distal pair of electrodes was used to stimulate the atrium while the proximal pair was used to record a high right atrial electrogram. His bundle electrograms were obtained as previously described using a tripolar electrode catheter. 27 Simultaneous recordings of standard electrocar- Al-H, is the A-H interval of the basic rhythm.
A2-H2 is the A-H interval of the stimulated atrial premature depolarization (APD).
H1-H2 is the interval between the His bundle depolarizations of the basic and the premature beat.
V1-V2 is the interval between the ventricular depolarizations of the basic and the premature beat.
Effective refractory period (ERP) of the atrium is defined as the longest S1-S2 interval at which S2 does not result in atrial depolarization. Effective refractory period (ERP) of the A-V node is the longest A1-A2 interval at which A2 fails to conduct to the bundle of His.
Functional refractory period (FRP) of the A-V node is the shortest interval between H1-H2 both of which are propagated from the atrium.
Effective refractory period (ERP) of the HisPurkinje system is the longest H1-H2 interval at which H2 fails to conduct to the ventricles.
Relative refractory period (RRP) of the His-Purkinje system is the longest H1-H2 at which H2 conducts to *Electronics-for-Medicine, White Plains, New York. effective refractory period of the atria decreased by an average of 22 msec. Six subjects demonstrated no change following DPH. These changes were not clinically significant (P > 0.4).
A-V node: Effective refractory period. The effective refractory period of the A-V node could be determined in only nine patients. In the remaining five subjects, the effective refractory period of the atria was first encountered. In six subjects DPH shortened the effective refractory period of the A-V node by an average of 46 msec. Figure 1 is representative of these findings. In three subjects it was prolonged by 33 msec.
Functional refractory period. DPH had variable effects on the functional refractory period of the A-V node. In six patients the functional refractory period of the A-V node was shortened by an average of 36 msec and in three it was prolonged by an average of 23 msec. In the remaining five subjects there was no change.
His-Purkinje system: Relative refractory period. The relative refractory period of the His-Purkinje system was significantly shortened in 7/7 subjects. The average change was 30 msec (P < 0.005). Figure 2 depicts this finding.
Effective refractory period. The effective refractory period of the His-Purkinje system could only be determined in one subject. There was shortening of the effective refractory period by 10 msec.
Blood levels. also complained of Table 4 Diphenylhydantoin Blood Levels (,ug/ml) Diphenylhydantoin has been reported to both enhance and delay A-V nodal conduction time. 9' 11, 12, 17, 20-22 In a previous report from this laboratory,'2 DPH was found to consistently enhance A-V nodal conduction in man. The results of the present study are less consistent; however a majority of patients (10) demonstrated enhanced A-V nodal conduction following the drug while in four patients conduction was delayed. Consistent with these findings is the fact that in a majority of patients (six of nine), DPH resulted in a shortening of the effective refractory period of the A-V node.
Microelectrode studies have demonstrated that the effects of DPH on the electrophysiologic properties of atrial tissue differ from those effects on Purkinje fibers. 19 23 The variable effects of DPH on atrial refractoriness in this study are consistent with the clinical observation that this drug, for the most part, is ineffective in the treatment of most atrial arrhythmias.
The therapeutic blood level of DPH for the treatment of most ventricular arrhythmias is generally between 10 and 18 .tg/ml." Effectiveness can also be seen at lower levels. In the present study, the effects of DPH on the electrophysiologic properties of the A-V conducting system were studied at blood levels known to be therapeutic for most ventricular arrhythmias.
